We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$41B
AUM Growth
+$146M
(+0.36%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.25%
Top 10 Holdings %
Top 10 Hldgs %
14.19%
Holding
825
New
119
Increased
275
Reduced
226
Closed
119
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$226M |
| 2 |
AGN
Allergan plc
AGN
|
+$166M |
| 3 |
NRF
NorthStar Realty Finance Corp.
NRF
|
+$152M |
| 4 |
Procter & Gamble
PG
|
+$150M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$382M |
| 2 |
AGN
Allergan Inc
AGN
|
+$274M |
| 3 |
CF Industries
CF
|
+$189M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$164M |
| 5 |
ROC
ROCKWOOD HLDGS INC
ROC
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.99% |
| 2 | Technology | 12.21% |
| 3 | Financials | 11% |
| 4 | Industrials | 9.97% |
| 5 | Consumer Discretionary | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Puma Biotechnology
PBYI
$408M
| $1.34B | 3.27% |
5,686,668
| – | – |
|
2
Apple
AAPL
$4.72T
| $1.1B | 2.69% |
35,489,008
-540,800
| -2% | -$16.3M |
|
3
Microsoft
MSFT
$2.83T
| $486M | 1.19% |
11,961,455
-417,700
| -3% | -$18.2M |
|
4
Alphabet (Google) Class C
GOOG
$3.89T
| $483M | 1.18% |
17,566,457
+1,281,509
| +8% | +$34.3M |
|
|
5
Bristol-Myers Squibb
BMY
$126B
| $455M | 1.11% |
7,053,191
+2,275,000
| +48% | +$142M |
|
6
ExxonMobil
XOM
$650B
| $446M | 1.09% |
5,243,992
-165,000
| -3% | -$14.6M |
|
7
Berkshire Hathaway Class B
BRK.B
$1.06T
| $407M | 0.99% |
2,818,877
+66,100
| +2% | +$9.73M |
|
8
Wells Fargo
WFC
$261B
| $383M | 0.93% |
7,033,588
-1,395,000
| -17% | -$75.4M |
|
9
JPMorgan Chase
JPM
$930B
| $359M | 0.88% |
5,931,807
+1,240,000
| +26% | +$73.4M |
|
10
GE Aerospace
GE
$362B
| $357M | 0.87% |
3,003,056
-1,254,490
| -29% | -$149M |
|
11
Honeywell
HON
$78B
| $351M | 0.86% |
3,750,127
+1,126,173
| +43% | +$103M |
|
|
12
Procter & Gamble
PG
$342B
| $322M | 0.79% |
3,930,989
+1,750,000
| +80% | +$150M |
|
13
Pfizer
PFE
$143B
| $314M | 0.77% |
9,521,287
+606,050
| +7% | +$19.3M |
|
|
APC
14
DELISTED
Anadarko Petroleum
APC
| $300M | 0.73% |
3,621,214
-760,000
| -17% | -$62.2M |
|
|
MNK
15
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $286M | 0.7% |
2,256,645
-1,437,455
| -39% | -$164M |
|
16
Chevron
CVX
$387B
| $286M | 0.7% |
2,721,133
+350,000
| +15% | +$37.4M |
|
17
Johnson & Johnson
JNJ
$624B
| $284M | 0.69% |
2,825,853
+181,999
| +7% | +$18.5M |
|
|
NBL
18
DELISTED
Noble Energy, Inc.
NBL
| $277M | 0.67% |
5,654,942
+285,000
| +5% | +$13.3M |
|
19
RTX Corp
RTX
$282B
| $270M | 0.66% |
3,653,915
+277,652
| +8% | +$20.7M |
|
20
Meta Platforms (Facebook)
META
$1.54T
| $267M | 0.65% |
3,247,000
-264,000
| -8% | -$20.7M |
|
21
Coca-Cola
KO
$349B
| $263M | 0.64% |
6,479,482
-3,490,000
| -35% | -$146M |
|
22
Citigroup
C
$221B
| $247M | 0.6% |
4,802,088
+115,000
| +2% | +$5.86M |
|
23
Walt Disney
DIS
$161B
| $246M | 0.6% |
2,347,612
+381,600
| +19% | +$38.5M |
|
24
Bank of America
BAC
$430B
| $246M | 0.6% |
15,988,586
-650,000
| -4% | -$10.4M |
|
|
25
Medtronic
MDT
$105B
| $232M | 0.57% |
+2,976,347
| New | +$226M |
|
Similar funds
Adage Capital Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Adage Capital Partners held 825 positions worth $41B, up 0.36% from $40.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q1 2015, closing 119 positions and reducing 226 holdings. Its most notable exit was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $382M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in Medtronic worth $232M.
- Adage Capital Partners's largest Q1 2015 buy was Medtronic: 2,976,347 shares worth $232M.
- Adage Capital Partners added most to Allergan plc in Q1 2015, an estimated $166M increase.
- Adage Capital Partners's biggest Q1 2015 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $164M.
- Adage Capital Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $382M.
- Adage Capital Partners's ten largest holdings make up 14% of its $41B portfolio in Q1 2015.
- Adage Capital Partners opened 119 new positions and closed 119 in Q1 2015.
- Adage Capital Partners's portfolio value rose 0.36% quarter-over-quarter to $41B.
Based on Adage Capital Partners's 13F filing for Q1 2015, filed 15 May 2015.